Scilex Holding (NASDAQ: SCLX) had its price target lowered by analysts at D. Boral Capital from $22.00 to $18.00. They now have a "buy" rating on the stock.
Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to
Scilex Holding (NASDAQ: SCLX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $22.00 price target on the stock.
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025 [Yahoo! Finance]